Company: LNAI
Filing Date: 2025-10-15
Form Type: DEF 14A
Source: 0001731122-25-001378
Chunk: 17

Company: Lunai Bioworks Inc.
Filing Date: 2025-10-15
Form: DEF 14A
Chunk 17
---
 at the Annual Meeting

Although we do not have a formal
policy regarding attendance by members of the Board at the Annual Meeting, we encourage all of our directors to attend. The Company did
not hold an annually meeting for the fiscal year end June 30, 2024.

Committees of the Board of Directors

The Board delegates various responsibilities
and authority to different board committees. Committees regularly report on their activities and actions to the full board. Currently,
the Board has established an Audit Committee, a Compensation Committee, and a Nominating and Corporate Governance Committee. Committee
assignments are re-evaluated annually. Each of these standing committees operates under a charter that has been approved by our Board.
The current charter of each of the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee is available
on our website at www.lunaibioworks.com.

The following table sets forth
the membership of each of the Board committees listed above.

| Name             |     | Audit Committee |     | Compensation 
 Committee    |     | Nominating and       
 Corporate Governance 
 Committee            |
| James McNulty    |     | Chair           |     | Chair        |     | X                    |
| Douglas Calder   |     | X               |     | X            |     | Chair                |
| Dr. Mark Collins |     | X               |     | X            |     | X                    |

Audit Committee

The Audit Committee has been structured
to comply with the requirements of Rule 10A-3(b)(1) promulgated under the Securities Exchange Act of 1934, as amended (the “”), and the listing standards of NASDAQ, and each member and former member of the Audit Committee complied with such requirements
and standards. The members of the Audit Committee are currently James McNulty (Chair), Douglas Calder and Dr. Mark Collins.

<div align='center'>11</div>

The Audit Committee oversees and
reports to our Board on various auditing and accounting-related matters, including, among other things, the maintenance of the integrity
of our financial statements, reporting process and internal controls; the selection, evaluation, compensation, and retention of our independent
registered public accounting firm; legal and regulatory compliance, including our disclosure controls and procedures; and oversight over
our risk management policies and procedures. The Audit Committee appoints and sets the compensation for the independent registered public
accounting firm annually and reviews and evaluates such auditor. This external auditor reports directly to the Audit Committee. The Audit
Committee establishes